CERVICAL CANCERS
Clinical trials for CERVICAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCERS trials appear
Sign up with your email to follow new studies for CERVICAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with AKT1 mutation
Disease control OngoingThis early-stage study tests an experimental pill, ATV-1601, in people with advanced solid tumors (including certain breast, ovarian, and prostate cancers) that have a specific AKT1 gene mutation. The main goals are to check the drug's safety, find the best dose, and see how the …
Matched conditions: CERVICAL CANCERS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Cervical cancer study pulled before it began
Disease control TerminatedThis study was designed for people with cervical cancer that had spread to nearby lymph nodes after surgery. It aimed to compare a combination of chemotherapy and immunotherapy against the usual treatment of chemotherapy plus radiation. The goal was to see which approach better p…
Matched conditions: CERVICAL CANCERS
Phase: PHASE2, PHASE3 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug combo shows promise for tough cervical cancer cases
Disease control OngoingThis study tests whether adding the drug toripalimab to standard chemoradiation can help people with high-risk, locally advanced cervical cancer live longer without the cancer getting worse. The trial involves 57 participants who have not had prior treatment. After the initial tr…
Matched conditions: CERVICAL CANCERS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
At-Home HPV test could revolutionize cervical cancer screening in indonesia
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether women can collect their own samples to screen for HPV, the virus that causes cervical cancer. About 8,000 women aged 30-69 in Indonesia will try the self-collection method at home or in a clinic. The goal is to see if this approach is effective and p…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: Dharmais National Cancer Center Hospital • Aim: Diagnosis
Last updated May 26, 2026 03:58 UTC
-
Mail-In HPV test could boost cervical cancer screening in quebec
Diagnosis OngoingThis study looks at whether letting women collect their own samples for HPV testing at home or in community locations can increase cervical cancer screening rates. About 1,000 women in Quebec aged 25-65 will try different ways to get and return a self-sampling kit. The goal is to…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated May 18, 2026 11:58 UTC
-
ERs may help catch cervical cancer early in underscreened groups
Knowledge-focused OngoingThis study looks at whether offering cervical cancer screening in the emergency department can help reach people who are not getting screened regularly. About 200 women and transgender/non-binary individuals with a cervix, aged 25-65, will be offered self-sampling or clinic-based…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 26, 2026 04:05 UTC
-
Real stories, real impact: new study aims to boost cancer screening in rural india
Knowledge-focused OngoingThis study tests whether a campaign featuring real stories from cancer survivors (Lived Experience Communication Campaign) can encourage more people in rural Tamil Nadu to get screened for oral, breast, and cervical cancers compared to standard awareness methods. About 1,120 men …
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: International Agency for Research on Cancer • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC